Endocrine and Hormonal Control of Blood Pressure
This paper examines the endocrine mechanisms governing arterial blood pressure (BP) regulation, with particular emphasis on the renin-angiotensin-aldosterone system (RAAS). It describes how peripheral sensory information is integrated in the brain to coordinate sympathetic, hormonal, and behavioral responses to changes in BP and fluid electrolyte content. The paper details the enzymatic cascade from angiotensinogen through angiotensin I and II, the opposing roles of AT1 and AT2 receptors, and the downstream effects on renal sodium and water handling. It also covers the emerging role of angiotensin (1-7) and ACE2 as a counter-regulatory pathway protecting against angiotensin-mediated hypertension.
- Overview of Blood Pressure Regulation: Neural integration of BP, osmolality, and electrolyte signals
- The Renin-Angiotensin-Aldosterone System: Renin, angiotensin I and II, and ACE1 cascade
- Angiotensin II Receptors and Renal Effects: AT1 vs AT2 receptor actions and kidney roles
- The ACE2 Counter-Regulatory Pathway: Angiotensin (1-7) as protective antagonist
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Moves logically from broad neurological integration to specific molecular cascades, giving the reader a clear scaffold before introducing biochemical detail.
- Uses precise anatomical and molecular terminology (e.g., juxtaglomerular cells, macula densa, 453-aa protein) appropriately, demonstrating command of the subject matter.
- Balances mechanistic description with functional consequence — each enzymatic step is paired with its physiological outcome (vasoconstriction, natriuresis, etc.).
- Incorporates a counter-regulatory pathway (ACE2/angiotensin 1-7) to acknowledge complexity and avoid an overly one-sided account.
Key academic technique demonstrated
The paper demonstrates systematic pathway analysis: it traces a single physiological variable (blood pressure) through multiple regulatory layers — neural, hormonal, and renal — and shows how each layer feeds back on the others. This technique is characteristic of strong biomedical writing, where understanding a phenomenon requires integrating information across organ systems rather than treating each in isolation.
Structure breakdown
The paper opens with an overview of neural integration centers and neurotransmitter systems involved in BP sensing. It then narrows to the RAAS enzymatic cascade and its primary effector, angiotensin II. The third section details angiotensin II receptor subtypes and their opposing physiological roles, with emphasis on renal effects. The paper closes by introducing the ACE2/angiotensin (1-7) alternate pathway as a protective counter-regulatory mechanism.
Overview of Blood Pressure Regulation
Arterial blood pressure (BP) is under tight control by the mammalian nervous system, cardiovascular system, kidneys, and endocrine system (Vivas et al., 2014). The VII, IX, and X cranial nerves conduct peripheral taste, osmo-sodium, volume, and baroreceptor information to the solitary tract, while distinct bundles of neurons in the lamina terminalis respond to changes in plasma and cerebrospinal fluid sodium levels, osmolality, and angiotensin II levels. The information received is then transmitted to the median preoptic, supraoptic, paraventricular, lateral parabrachial, and dorsal raphe nuclei for integration. The neurotransmitter systems involved include angiotensin, vasopressin, oxytocin, and serotonin.
The overall response to reductions in BP and electrolyte content of bodily fluids is to trigger the sympathetic nervous system, endocrine system, and appropriate behavior to correct the deficiency (Vivas et al., 2014).
The Renin-Angiotensin-Aldosterone System
The most important arm of BP control is the renin-angiotensin-aldosterone system (RAAS), which mediates both short-term and long-term BP regulation (Chopra, Baby, and Jacob, 2011). Plasma angiotensinogen, a 453-amino acid protein, is produced by the liver and enzymatically cleaved by renin to produce the 10-amino acid peptide angiotensin I, which induces mild vasoconstriction. Renin is produced by the juxtaglomerular cells in response to baroreceptor activation due to low BP, detection of low sodium levels in the macula densa ultrafiltrate, and sympathetic nervous system activation (Farrao, Lara, & Lowe, 2014).
Angiotensin I can be further cleaved by angiotensin-converting enzyme 1 (ACE1), primarily in the lungs, to produce the 8-amino acid angiotensin II, which induces arterial constriction and a measurable increase in BP. ACE1 also inactivates bradykinin, further promoting an increase in BP (Duka et al., 2006).
Create your account
Always verify citation format against your institution’s current style guide requirements.